Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
6.45
-0.35 (-5.15%)
At close: Jun 17, 2025, 3:59 PM
6.42
-0.47%
After-hours: Jun 17, 2025, 04:23 PM EDT
-5.15% (1D)
| Bid | 6.02 |
| Market Cap | 348.17M |
| Revenue (ttm) | 80M |
| Net Income (ttm) | -510K |
| EPS (ttm) | -0.01 |
| PE Ratio (ttm) | -645 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 6.64 |
| Volume | 383,386 |
| Avg. Volume (20D) | 549,185 |
| Open | 6.78 |
| Previous Close | 6.80 |
| Day's Range | 6.34 - 6.81 |
| 52-Week Range | 2.31 - 10.13 |
| Beta | 2.42 |
About FULC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FULC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FULC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+17.23%
Fulcrum Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
8 months ago
+15.27%
Fulcrum Therapeutics shares are trading higher after Pfizer withdrew its sickle cell treatment.
